Description

(1-Methyl-4-Oxo-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetic Acid is a high-purity, advanced pharmaceutical intermediate belonging to the pyrazolopyrimidine class of heterocyclic compounds. This compound is valued for its role as a critical building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly those targeting specific enzymatic pathways. It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, especially kinase inhibitors.
• Biochemical Research: Used as a reference standard or building block in medicinal chemistry for structure-activity relationship (SAR) studies.
• API Development: Integral to the production route of target-specific active pharmaceutical ingredients for preclinical and clinical trials.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Utilized in university and institutional labs for exploring new therapeutic applications of pyrazolopyrimidine derivatives.

Basic Information

Product Name	(1-Methyl-4-Oxo-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetic Acid
CAS No.	923230-33-5
Molecular Formula	C9H8N4O3
Molecular Weight	220.19 g/mol
Synonyms	5H-Pyrazolo[3,4-d]pyrimidin-5-ylacetic acid, 1-methyl-4-oxo-1,4-dihydro-; 1-Methyl-4-oxo-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-ylacetic acid; (1-Methyl-4-oxo-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)acetic acid; 5H-Pyrazolo[3,4-d]pyrimidine-5-acetic acid, 1,4-dihydro-1-methyl-4-oxo-; 923230-33-5; 1-Methyl-4-oxo-1,4-dihydropyrazolo[3,4-d]pyrimidin-5-ylacetic acid
EINECS	Contact for details

Quality Control

Our (1-Methyl-4-Oxo-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specified parameters. Our quality commitment supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product should be kept under an inert atmosphere if long-term storage is required to prevent potential degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.